Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part of talks with the U.S. government, which is pressuring drugmakers to cut ...

The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

If we don’t incentivize continued investments in drug research and development, we’ll lose out on new therapies that don’t ...

ADI shares flashed a Golden Cross pattern on July 1, when the 50-day moving average crossed above the 200-day, a classic signal of long-term momentum shifting to the upside. This follows a successful ...

Prescription drugs account for 15% of health care costs. Yet, they’re our best defense against the chronic diseases that ...

President Donald Trump’s “big, beautiful bill,” which he signed into law earlier this month, includes major wins for business ...

Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...

Drug development is a decade-long, costly process replete with failures. If we don’t incentivize investments in research and ...

(Reuters) -Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, ...

Even ironclad plans can be turned molten in the heat of the moment, so trying to establish any degree of economic equilib­rium in a world where Donald Trump’s thumb is firmly on the scales can feel ...

President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...